electroCore, Inc. (NASDAQ:ECOR – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 64,900 shares, an increase of 19.7% from the September 15th total of 54,200 shares. Approximately 1.2% of the shares of the company are short […]
11.10.2023 - ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to a .
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
ROCKAWAY, N.J., Oct. 09, 2023 electroCore, Inc. , a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the third quarter.
27.09.2023 - Two prospective, peer reviewed trials demonstrate the symptomatic benefit of gammaCore in patients with PTSDROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness . Seite 1